AlphaGrep UK’s Labcorp LH Stock Holding History

AlphaGrep UK’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,479	Closed	-$395K	–	851
2026 Q1	$395K	Sell	1,479 -158	-10%	-$42.8K	0.11%	364
2025 Q4	$411K	Buy	+1,637	New	+$435K	0.14%	276

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AlphaGrep UK's LH Position: Q2 2026 in Review

AlphaGrep UK sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,479 shares — an estimated $395K sold.

AlphaGrep UK first reported a position in LH in Q4 2025 and held it in 2 quarters. The position peaked at $411K in Q4 2025. 1,005 funds tracked by Wall St. Rank hold LH as of Q2 2026.

AlphaGrep UK reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,479 Labcorp shares in Q2 2026, an estimated $395K.
AlphaGrep UK first reported a position in Labcorp in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Labcorp position peaked at $411K in Q4 2025.
1,005 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.